KAIST researchers have developed a method that attaches DNA fragments to mRNA to slow the onset of protein production, ...
RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...
RNA, widely known from the COVID-19 vaccine, is not actually a “therapeutic agent,” but a technology that delivers the ...
The 5th mRNA-Based Therapeutics Summit Europe is the leading European industry-focused forum dedicated to accelerating the ...
RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the blueprint for functional ...
The Department of Health and Human Services recently canceled $500 million in funding for vaccine research that it had previously pledged to scientists.
Medindia on MSN
New MRNA Strategy May Protect Muscles After Snakebite
A new preclinical study shows that mRNA delivered through lipid nanoparticles can trigger local antibody production in muscle ...
TriLink BioTechnologies senior scientist Dr Cody Palumbo discusses the blockers to manufacturing mRNA-based gene editing ...
While mRNA vaccines trigger potent initial immune responses, emerging data suggest they do not generate durable plasma cells, ...
The Food and Drug Administration is seeking to drastically change procedures for testing vaccine safety and approving vaccines.
A new approach has been proposed to suppress the side effects of messenger ribonucleic acid (mRNA), opening up possibilities ...
In two experiments, researchers have found that introducing people to "mental models" about how mRNA vaccination works and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback